For complete details about these proceedings, click here.
PMNOC Proceedings
rivaroxaban (XARELTO): Bayer v Teva
lenalidomide (REVLIMID): Celgene v Apotex
ticagrelor (BRILINTA): AstraZeneca v Taro
silodosin (RAPAFLO): Allergan v Sandoz and Kissei
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
